Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
176M
-
Number of holders
-
76
-
Total 13F shares, excl. options
-
89.7M
-
Shares change
-
-782K
-
Total reported value, excl. options
-
$177M
-
Value change
-
-$1.7M
-
Number of buys
-
37
-
Number of sells
-
-23
-
Price
-
$1.97
Significant Holders of Compass Therapeutics, Inc. - Common Stock, par value $0.0001 per share (CMPX) as of Q3 2023
80 filings reported holding CMPX - Compass Therapeutics, Inc. - Common Stock, par value $0.0001 per share as of Q3 2023.
Compass Therapeutics, Inc. - Common Stock, par value $0.0001 per share (CMPX) has 76 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 89.7M shares
of 176M outstanding shares and own 50.86% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (22.4M shares), JANUS HENDERSON GROUP PLC (6.66M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (6.38M shares), Blackstone Inc. (6.19M shares), BlackRock Inc. (5.97M shares), BRAIDWELL LP (5.95M shares), Rock Springs Capital Management LP (5.51M shares), FMR LLC (4.55M shares), VANGUARD GROUP INC (4.11M shares), and Vivo Capital, LLC (3.56M shares).
This table shows the top 76 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.